急性缺血性脑卒中患者溶栓术后预防出血转化的最佳证据总结

doi:10.16460/j.issn1008-9969.2021.03.046

摘要/Abstract

摘要： 目的选取国内外急性缺血性脑卒中溶栓术后患者预防出血转化的相关证据,并对最佳证据进行总结,为护理人员降低脑梗死溶栓术后出血转化提供参考。方法使用计算机检索Cochrane Library、JBI、BMJ、PubMed、Up To Date、NGC、GIN、SIGN、NZGG、NICE、RNAO、中国知网、维普、万方数据库、中国生物医学数据库,并检索了美国心脏学会/美国卒中学会网站、欧洲卒中组织网站、加拿大卒中网站,从中遴选出符合纳入标准的文献。由2名研究员对文献质量进行独立评价、证据提取和证据综合。结果共纳入17篇文献,其中指南9篇,系统评价5篇,专家共识/立场声明3篇。从 17 篇文献中共提取了 26 条证据,综合成 7 个维度分别是危险因素、病情监测、血压管理、症状识别、对症处理、药物管理、饮食管理。结论要以基于循证的标准化预防策略解决急性脑梗死溶栓后出血转化的问题,应用证据时需结合我国国情、临床实际和患者意愿,有针对性地选择证据,促进最佳证据应用于急性缺血性脑卒中溶栓术后出血转化的预防和管理,从而降低脑梗死溶栓术后出血转化发生率,促进护理质量的持续改进,改善患者的临床结局,提升患者的满意度。

关键词: 急性缺血性脑卒中, 溶栓, 出血转化, 症状性脑出血, 循证护理

Abstract: Objective To summarize the best evidence for the prevention of hemorrhagic transformation after thrombolysis in patients with acute ischemic stroke and to provide reference for nursing staff to reduce the incidence of hemorrhagic transformation after thrombolysis of stroke. Methods We searched Cochrane Library, JBI, BMJ, PubMed, UpToDate, NGC, GIN, SIGN, NZGG, NICE, RNAO, CNKI, Vip Datebase, Wanfang Datebase, CBM and AHA/ASA, ESO and Canadian Stroke Best Practices for eligible literature. Two researchers independently appraised articles, and extracted data from eligible studies. Results Seventeen articles were enrolled, including 9 guidelines, 5 systematic reviews, 3 expert consensuses/position statement. Totally 26 items of best evidence were summarized from seven aspects：risk factors, condition monitoring, blood pressure management, symptom identification, symptomatic treatment, medication management and diet management. Conclusion Evidence-based standardized prevention strategy should be adopted for the prevention of hemorrhagic transformation after thrombolysis of acute ischemic stroke. It is necessary to select evidence according to the national conditions, clinical practice and patients' wishes. When applying evidence, the best evidence should be applied to the prevention and management of haemorrhage transformation after thrombolysis of acute ischemic stroke, so as to reduce the incidence of hemorrhagic transformation, promote the continuous improvement of nursing quality, the clinical outcome of patients and the satisfaction of patients.

Key words: acute ischemic stroke, thrombolysis, hemorrhagic transformation, symptomatic intracerebral hemorrhage, evidence-based nursing

中图分类号:

R473.74

王亚玲, 王冰寒, 张艳, 尹雪, 蒋辛, 熊晓明, 黎华丽. 急性缺血性脑卒中患者溶栓术后预防出血转化的最佳证据总结[J]. 护理学报, 2021, 28(3): 46-52.

WANG Ya-ling, WANG Bing-han, ZHANG Yan, YIN Xue, JIANG Xin, XIONG Xiao-ming, LI Hua-li. Best Evidence Summary for Prevention of Hemorrhagic Transformation after Thrombolysis in Patients with Acute Ischemic Stroke[J]. Journal of Nursing, 2021, 28(3): 46-52.

参考文献

[1] Wang W,Jiang B,Sun H,et al.Prevalence,Incidence,and Mortality of Stroke in China:Results from a Nationwide Population.Based Survey of 480 687 Adults[J]. Circulation,2017,135(8):759-771.DOI:10.1161/CIRCULATIONAHA.116.025250.
[2] Wang D, Liu J,Liu M,et a1.Patterns of Stroke Between Universitv Hospitals and Nonuniversity Hospitals in Mainland China:Prospective Muhicenter Hospital-based Registry Study[J]. World Neurosurg,2017,98(2):258-265. DOI:10.1016/j.wneu.2016.11.006.
[3] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018, 51(9):666-682.DOI:10.3760/cma.j.issn.1006-7876.2018.09.004.
[4] Kernan WN, Ovbiagele B, Black H R, et al.Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association[J]. Stroke,2014,45(7):2160-2236. DOI:10.1161/STR.0000000000000024.
[5] Coutts SB, Wein TH, Lindsay MP, et al.Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Guidelines, Update 2014[J]. Int J Stroke, 2014, 23(10):924-940. DOI:10.1111/ijs.12439.
[6] Minematsu K.Intravenous Rt-Pa Therapy: Current Status and Extending Therapeutic Time Window in Japan[J]. Rinsho Shinkeigaku, 2013, 53(11):1163-1165. DOI:10.5692/clinicalneurol.53.1163.
[7] Yaghi S, Willey JZ, Cucchiara B, et al.Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in Acute Ischemic Stroke: A Scientific Statement for Healthcare Professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2017, 48(12): e343-e361. DOI:10.1161/STR.0000000000000152.
[8] Seet RC, Rabinstein AA.Symptomatic Intracranial Hemorrhage Following Intravenous Thrombolysis for Acute Ischemic Stroke: A Critical Review of Case Definitions[J].Cerebrovasc Dis, 2012, 34(2):106-114. DOI:10.1159/000339675.
[9] Dharmasaroja PA, Dharmasaroja P, Muengtaweepongsa S.Outcomes of Thai Patients with Acute Ischemic Stroke after Intravenous Thrombolysis[J]. J Neurol Sci,2011, 300(1-2): 74-77. DOI:10.1016/j.jns.2010.09.029.
[10] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性脑梗死后出血转化诊治共识2019[J].中华神经科杂志, 2019, 52(4):252-265.DOI:10.3760/cma.j.issn.1006-7876.2018.09.004.
[11] Mehta RH, Cox M, Smith EE, et al.Race/Ethnic Differences in the Risk of Hemorrhagic Complications Among Patients with Ischemic Stroke Receiving Thrombolytic Therapy[J]. Stroke, 2014, 45(8):2263-2269. DOI:10.1161/STROKEAHA.114.005019.
[12] Hao Y, Yang D, Wang H, et al.Predictors for Symptomatic Intracranial Hemorrhage after Endovascular Treatment of Acute Ischemic Stroke[J]. Stroke, 2017, 48(5):1203-1209. DOI:10.1161/STROKEAHA.116.016368.
[13] Lansberg MG, O'Donnell MJ, Khatri P, et al. Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl): e601S-e636S. DOI:10.1378/chest.11-2302.
[14] Steiner T, Al-Shahi Salman R, Beer R, et al. European Stroke Organisation (ESO) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage[J]. Int J Stroke,2014, 9(7):840-855. DOI:10.1111/ijs.12309.
[15] Casaubon LK, Boulanger JM, Glasser E, et al.Canadian Stroke Best Practice Recommendations: Acute Inpatient Stroke Care Guidelines,Update 2015[J]. Int J Stroke, 2016, 11(2):239-252. DOI:10.1177/1747493015622461.
[16] Aromataris E, Fernandez R, Godfrey CM, et al.Summarizing Systematic Reviews: Methodological Development, Conduct and Reporting of an Umbrella Review Approach[J].Int J Evid Based Healthc, 2015, 13(3):132-140.DOI:10.1097/XEB.0000000000000055.
[17] Brouwers MC, Kho ME, Browman GP, et al.AGREE II: Advancing Guideline Development, Reporting and Evaluation in Healthcare[J]. Can Med Assoc J, 2010, 182(18): E839-E842. DOI:10.1503/cmaj.090449.
[18] Shea BJ, Reeves BC, Wells G, et al.AMSTAR 2:A Critical Appraisal Tool for Systematic Reviews That Include Randomised or Non-randomised Studies of Healthcare Interventions or Both[J]. BMJ, 2017(358):j4008. DOI:10.1136/bmj.j4008.
[19] The Joanna Briggs Institute. Joanna Briggs Institute Reviewers' Manual:2016edition[M].Australia:The Joanna Briggs Institute, 2016.
[20] 王春青,胡雁.JBI证据预分级及证据推荐级别系统(2014版)[J].护士进修杂志,2015,30(11):964-967.
[21] 刘云访,喻姣花,李素云,等. ICU成人患者气管插管非计划性拔管预防及管理的证据总结[J]. 护理学报,2020,27(3):43-48.DOI:10.16460/j.issn1008-9969.2020.03.043.
[22] 李佳梅,陈鸿芳,刘宁,等. 脑梗死偏瘫患者良肢位管理的最佳证据总结[J]. 护理学报,2019,26(24):22-27.DOI:10.16460/j.issn1008-9969.2019.24.022.
[23] Liu L, Ding J, Leng X, et al.Guidelines for Evaluation and Management of Cerebral Collateral Circulation in Ischaemic Stroke 2017[J]. Stroke Vasc Neurol, 2018, 3(3):118-130. DOI:10.1136/svn-2017-000135.
[24] Furie KL, Jayaraman MV.2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke[J]. Stroke, 2018, 49(3):509-510. DOI:10.1161/STROKEAHA.118.020176.
[25] Tyrrell P, Swain S, Rudd A.NICE Guideline on Acute Stroke and TIA: Commentary[J]. Heart, 2009, 95(10):843-845. DOI:10.1136/hrt.2009.167684.
[26] Hemphill JC, Greenberg SM, Anderson CS, et al.Guidelines for the Management of Spontaneous Intracerebral Hemorrhage:A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association[J]. Stroke,2015,46(7):2032-2060. DOI:10.1161/STR.0000000000000069.
[27] Kernan WN, Ovbiagele B, Black HR, et al.Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association Published Correction Appears in Stroke[J]. Stroke, 2014, 45(7):2160-2236. DOI:10.1161/STR.0000000000000024.
[28] Prabhakaran S, Ruff I, Bernstein RA.Acute Stroke Intervention: A Systematic Review[J]. JAMA, 2015, 313(14):1451-1462. DOI:10.1001/jama.2015.3058.
[29] Appleton JP, Sprigg N, Bath PM.Blood Pressure Management in Acute Stroke[J]. Stroke Vasc Neurol, 2016, 1(2):72-82. DOI:10.1136/svn-2016-000020.
[30] Luo SY, Zhang M, Zeng WT, et al.Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy: A Systematic Review and Meta-analysis of 19 Studies[J]. J Am Heart Assoc, 2016,5(5):e003242. DOI:10.1161/JAHA.116.003242.
[31] Wardlaw JM, Murray V, Berge E, et al.Thrombolysis for Acute Ischaemic Stroke(Review)[J].Cochrane Database of Systematic Reviews,2014(7):1-145.DOI:10.1002/14651858.CD000213.pub3.
[32] Whiteley WN, Slot KB, Fernandes P, et al.Risk Factors for Intracranial Hemorrhage in Acute Ischemic Stroke Patients Treated with Recombinant Tissue Plasminogen Activator: A Systematic Review and Meta-analysis of 55 Studies[J]. Stroke, 2012, 43(11):2904-2909. DOI:10.1161/STROKEAHA.112.665331.
[33] Demaerschalk BM, Kleindorfer DO, Adeoye OM, et al.Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke[J]. Stroke,2016,47(2):581-641.DOI:10.1161/STR.0000000000000086.
[34] 吴娅,刘承春,李玮,等. 5种评分系统对不同时间窗急性脑梗死静脉溶栓后出血转化风险预测差异的比较研究[J]. 第三军医大学学报,2017,39(17):1744-1749.DOI:10.16016 /j.1000-5404.201702008.
[35] Yaghi S, Boehme AK, Dibu J, et al.Treatment and Outcome of Thrombolysis-related Hemorrhage: A Multicenter Retrospective Study[J]. JAMA Neurol, 2015,72(12):1451-1457.DOI:10.1001/jamaneurol.2015.2371.
[36] Hacke W, Kaste M, Fieschi C, et al.Randomised Double-blind Placebo-controlled Trial of Thrombolytic Therapy with Intravenous Alteplase in Acute Ischaemic Stroke (ECASS II).Second European-australasian Acute Stroke Study Investigators[J]. Lancet,1998, 352(9136):1245-1251.DOI:10.1016/s0140-6736(98)08020-9.
[37] Wahlgren N, Ahmed N, Eriksson N, et al.Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled Trials: Safe Implementation of Thrombolysis in Stroke-monitoring Study (SITS-MOST)[J]. Stroke,2008,39(12):3316-3322. DOI:10.1161/STROKEAHA.107.510768.
[38] Hao Y, Yang D, Wang H, et al.Predictors for Symptomatic Intracranial Hemorrhage after Endovascular Treatment of Acute Ischemic Stroke[J]. Stroke, 2017, 48(5):1203-1209.DOI:10.1161/STROKEAHA.11.016368.
[39] Zaidat OO, Castonguay AC, Gupta R, et al.North American Solitaire Stent Retriever Acute Stroke Registry: Post-marketing Revascularization and Clinical Outcome Results[J]. J Neurointerv Surg,2018, 10(Suppl 1):i45-i49.DOI:10.1136/neurintsurg-2013-010895.rep.

Metrics

Viewed

Full text

Abstract

Cited

Shared